Blog

[:content [\3 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \P \a \t \i \e \n \t \s \space \a \n \d \space \d \o \c \t \o \r \s \space \i \n \space \S \c \o \t \l \a \n \d \space \a \r \e \space \t \o \space \h \a \v \e \space \a \space \g \r \e \a \t \e \r \space \s \a \y \space \o \v \e \r \space \w \h \i \c \h \space \d \r \u \g \s \space \f \o \r \space \r \a \r \e \space \c \o \n \d \i \t \i \o \n \s " ..."]]

In April 2014 the EU Parliament and Council commissioned the European Medicines Agency (EMA) to establish a publicly accessible database ...

Eisai announced today that its German sales company Eisai GmbH has resubmitted its first-in-class anti-epilepsy drug Fycompa (perampanel) to the German Federal ...

In November 2014 PHARMAC issued a request for information from suppliers and wholesalers who may be interested in pursuing a listing ...

Eight health and community organisations have written to the Trade Minister Andrew Robb expressing "grave concerns" about the latest leaked ...

[:content [\T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \S \e \p \t \e \m \b \e \r \space \2 \0 \1 \3 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]

PHARMAC is pleased to announce that it has awarded Hospital Supply Status in DHB hospitals to Janssen-Cilag’s brand of infliximab, Remicade. In ...

The price the NHS in England agrees to pay for new medicines is too high, causing more harm than good ...

CADTH has received notices of pending submissions from BioMarin for galsulfase (Naglazyme) for patients with mucopolysaccharidosis type VI and from Amgen ...

[:content [\2 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \S \a \x \a \g \l \i \p \t \i \n \space \h \y \d \r \o \c \h \l \o \r \i \d \e \space \( \O \n \g \l \y \z \a \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \a \l \s \o \space \a \s \space \m \o \n \o \t \h \e \r \a \p \y \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \J \u \l \y \space \2 \0 \1 \3 \space \f \o \r \space \c \e \r \t \a \i \n " ..."]]

NICE has issued further draft guidance for consultation that recommends obinutuzumab, marketed by Roche as Gazyvaro, for some people with ...

Internationally health economic evaluations (HEEs) form a legally regulated fixed component in health-care decisions. This applies particularly to the drug ...

PHARMAC is seeking feedback on a proposal to list a range of wound care products supplied by ConvaTec (New Zealand) ...

CADTH has received notice of a pending submission from Amgen for Prolia (denosumab) for the treatment of men with osteoporosis.  For ...